ASMB logo

Assembly Biosciences (ASMB)

Profile

Full Name

Assembly Biosciences, Inc.

Ticker Symbol

ASMB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

December 17, 2010

Indexes

Not included

Website

http://www.assemblybio.com

Employees

73

Key Details

Price

$9.08(+7.33%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$28.52M(+298.16% YoY)

Annual EPS

-$6.69(+50.00% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$9.08
ASMB price is $9.08

30-Day Relative Volume

0.89
ASMB 30-day relative volume is 0.89

Price Performance

Price Most recent change

+7.33%
ASMB price was up +7.33% on Apr 11, 2025

Price YTD change

-42.46%
ASMB price is down -42.46% since January 1st

Price 1-year change

-39.71%
ASMB price is down -39.71% year-on-year

Price 3-year change

-65.29%
ASMB price is down -65.29% over the past 3 years

Price Range

Price All-time high

$1260.00
ASMB price is currently -99.28% below its historical high of $1260.00

Price 3-year low

$7.68
ASMB price is currently +18.23% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$68.13M
ASMB market capitalization is $68.13 million

Market cap 3-year change

-35.07%
ASMB market capitalization is down -35.07% over the past 3 years

Market cap All-time high

$1.30B
ASMB market capitalization is currently -94.76% below its historical high of $1.30 billion

Market cap sector rank

43.14%
ASMB market capitalization is higher than 43.14% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+36.85%
ASMB shares outstanding is up +36.85% year-on-year

Shares Outstanding 3-Year Change

+87.07%
ASMB shares outstanding is up +87.07% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.76
ASMB beta is 0.76

200-day SMA

$14.56
ASMB price is currently -37.63% below its 200-day simple moving average

50-day SMA

$11.47
ASMB price is currently -20.86% below its 50-day simple moving average

RSI

37.95
ASMB 14-day relative strength index is 37.95

Volume

0.89
ASMB 30-day relative volume is 0.89

ATR

$0.89
ASMB average true range is $0.89

10-day Historical Volatility

79.19%
ASMB 10-day historical volatility is 79.19%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$28.52M
ASMB annual revenue is $28.52 million

Revenue Analysts estimate

$30.98M
ASMB annual revenue is currently -7.96% lower than the consensus analysts' forecast

Revenue 1-year change

+298.16%
ASMB annual revenue is up +298.16% year-on-year

Revenue Sector rank

38.3%
ASMB annual revenue is higher than 38.3% of companies in Healthcare sector

EPS

EPS

-$6.69
ASMB annual earnings per share is -$6.69

EPS Analysts estimate

-$5.68
ASMB annual earnings per share is currently +17.78% higher than the consensus analysts' forecast

EPS 1-year change

+50%
ASMB annual earnings per share is up +50% year-on-year

EPS Sector rank

15.28%
ASMB annual earnings per share is higher than 15.28% of companies in Healthcare sector

Profit

Gross profit

-
ASMB annual gross profit value is unknown

Gross margin

-
ASMB annual gross profit margin value is unknown

Operating profit

-$45.42M
ASMB annual operating income is -$45.42 million

Operating margin

-159.26%
ASMB annual operating profit margin is -159.26%

Net income

-$40.18M
ASMB annual net profit is -$40.18 million

Net margin

-140.87%
ASMB annual net profit margin is -140.87%

Expenses

Total expenses

$73.94M
ASMB annual total expenses is $73.94 million

Operating expenses

$73.94M
ASMB annual total operating expenses is $73.94 million

Cost of goods sold

-
ASMB annual cost of goods sold value is unknown

Selling, general & administrative expenses

$18.01M
ASMB annual SGA is $18.01 million

Depreciation and amortization

$129.00K
ASMB annual depreciation & amortization is $129.00 thousand

Interest expense

-
ASMB annual interest expense value is unknown

Income tax

$330.00K
ASMB annual income tax is $330.00 thousand

EBIT & EBITDA

EBIT

-$45.42M
ASMB annual earnings before interest & taxes is -$45.42 million

EBITDA

-$45.29M
ASMB annual EBITDA is -$45.29 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$119.17M
ASMB annual total assets is $119.17 million

Non current assets

$3.67M
ASMB annual long term assets is $3.67 million

Current assets

$115.50M
ASMB annual total current assets is $115.50 million

Cash and cash equivalents

$38.34M
ASMB annual cash & cash equivalents is $38.34 million

Accounts receivable

$0.00
ASMB annual accounts receivable is $0.00

Inventory

-
ASMB annual inventory value is unknown

Liabilities

Total liabilities

$85.81M
ASMB annual total liabilities is $85.81 million

Long term liabilities

$38.01M
ASMB annual total long term liabilities is $38.01 million

Current liabilities

$47.80M
ASMB annual total current liabilities is $47.80 million

Accounts payable

$585.00K
ASMB annual accounts payable is $585.00 thousand

Debt

Total debt

$3.09M
ASMB annual total debt is $3.09 million

Total debt 1-year change

+31.9%
ASMB annual total debt is up +31.9% year-on-year

Long term debt

$2.63M
ASMB annual long term debt is $2.63 million

Short term debt

$461.00K
ASMB annual short term debt is $461.00 thousand

Equity & Capital

Shareholders equity

$33.36M
ASMB annual stockholders equity is $33.36 million

Book value

$33.36M
ASMB annual book value is $33.36 million

Retained earnings

-$825.92M
ASMB annual retained earnings is -$825.92 million

Working capital

$67.70M
ASMB annual working capital is $67.70 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$51.12M
ASMB annual cash flow from operations is -$51.12 million

Cash from operations 1-year change

-324.76%
ASMB annual cash flow from operations is down -324.76% year-on-year

Cash from investing

$40.17M
ASMB annual cash flow from investing activities is $40.17 million

Cash from investing 1-year change

+158.1%
ASMB annual cash flow from investing activities is up +158.1% year-on-year

Cash from financing

$29.45M
ASMB annual cash flow from financing activities is $29.45 million

Cash from financing 1-year change

+113.12%
ASMB annual cash flow from financing activities is up +113.12% year-on-year

CAPEX

CAPEX

$28.00K
ASMB annual capital expenditures is $28.00 thousand

CAPEX 1-year change

-89.02%
ASMB annual capital expenditures is down -89.02% year-on-year

Free Cash Flow

Free cash flow

-$51.15M
ASMB annual free cash flow is -$51.15 million

Free cash flow 1-year change

-327.43%
ASMB annual free cash flow is down -327.43% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ASMB annual gross profit margin value is unknown

Operating margin

-159.26%
ASMB annual operating profit margin is -159.26%

Net margin

-140.87%
ASMB annual net profit margin is -140.87%

ROA & ROE

ROA

-31.39%
ASMB annual return on assets is -31.39%

ROE

-107.92%
ASMB annual return on equity is -107.92%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ASMB price to earnings ratio value is unknown

PE ratio Sector rank

-
ASMB price to earnings ratio is unknown

PB Ratio

PB ratio

2.04
ASMB price to book ratio is 2.04

PB ratio Sector rank

63.57%
ASMB price to book ratio is higher than 63.57% of companies in Healthcare sector

PS Ratio

PS ratio

2.39
ASMB price to sales ratio is 2.39

PS ratio Sector rank

46.28%
ASMB price to sales ratio is higher than 46.28% of companies in Healthcare sector

Enterprise value

Enterprise value

$32.88M
ASMB enterprise value is $32.88 million

Enterprise value Sector rank

37.08%
ASMB enterprise value is higher than 37.08% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.73
ASMB EV/EBITDA is -0.73

EV/EBITDA Sector rank

47.26%
ASMB EV/EBITDA is higher than 47.26% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.42
ASMB annual current ratio is 2.42

Quick ratio

-
ASMB annual quick ratio value is unknown

Leverage

Debt to equity

0.00
ASMB annual debt to equity ratio is 0.00

Interest coverage ratio

-
ASMB annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ASMB piotroski f-score value is unknown

Altman Z-Score

-9.56
ASMB altman z-score is -9.56

Analyst ratings

Recent major analysts updates

Mar 25, 25 Guggenheim
Buy
Mar 24, 25 HC Wainwright & Co.
Neutral
Dec 27, 24 HC Wainwright & Co.
Neutral
Jun 20, 24 HC Wainwright & Co.
Neutral
Jun 13, 24 HC Wainwright & Co.
Neutral
Apr 1, 24 HC Wainwright & Co.
Neutral
Mar 24, 23 HC Wainwright & Co.
Neutral
Nov 16, 22 Mizuho
Buy
Oct 24, 22 Truist Securities
Hold
Apr 1, 22 Truist Securities
Buy

Institutional Ownership

Similar stocks

MNOV logo
MediciNova (MNOV)
VTYX logo
Ventyx Biosciences (VTYX)
ABOS logo
Acumen Pharmaceuticals (ABOS)
GNTA logo
Genenta Science SpA (GNTA)
VIGL logo
Vigil Neuroscience (VIGL)
ZYXI logo
Zynex (ZYXI)
CNTX logo
Context Therapeutics (CNTX)
Alpha Cognition (ACOG)
MLSS logo
Milestone Scientific (MLSS)
  • What is the ticker symbol for Assembly Biosciences?
  • Does Assembly Biosciences pay dividends?
  • What sector is Assembly Biosciences in?
  • What industry is Assembly Biosciences in?
  • What country is Assembly Biosciences based in?
  • When did Assembly Biosciences go public?
  • Is Assembly Biosciences in the S&P 500?
  • Is Assembly Biosciences in the NASDAQ 100?
  • Is Assembly Biosciences in the Dow Jones?
  • When was Assembly Biosciences's last earnings report?
  • When does Assembly Biosciences report earnings?
  • Should I buy Assembly Biosciences stock now?

What is the ticker symbol for Assembly Biosciences?

The ticker symbol for Assembly Biosciences is NASDAQ:ASMB

Does Assembly Biosciences pay dividends?

No, Assembly Biosciences does not pay dividends

What sector is Assembly Biosciences in?

Assembly Biosciences is in the Healthcare sector

What industry is Assembly Biosciences in?

Assembly Biosciences is in the Biotechnology industry

What country is Assembly Biosciences based in?

Assembly Biosciences is headquartered in United States

When did Assembly Biosciences go public?

Assembly Biosciences's initial public offering (IPO) was on December 17, 2010

Is Assembly Biosciences in the S&P 500?

No, Assembly Biosciences is not included in the S&P 500 index

Is Assembly Biosciences in the NASDAQ 100?

No, Assembly Biosciences is not included in the NASDAQ 100 index

Is Assembly Biosciences in the Dow Jones?

No, Assembly Biosciences is not included in the Dow Jones index

When was Assembly Biosciences's last earnings report?

Assembly Biosciences's most recent earnings report was on Mar 20, 2025

When does Assembly Biosciences report earnings?

The next expected earnings date for Assembly Biosciences is May 8, 2025

Should I buy Assembly Biosciences stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page